Drug allergy
Penicillin allergy — 90% of people who think they have one don't. Here's how to find out.
A penicillin allergy label on your chart can push you toward second-line antibiotics that work less well and cost more. The label is removable. Here's how de-labeling works in 2026 and why every NYC adult with the label should consider it.
Published May 20, 2026 · 8 min read

Medically reviewed by Dr. Robert Tamayev, MD, PhD · Updated May 20, 2026
Key takeaways
- About 10% of Americans carry a penicillin allergy label on their chart. Fewer than 1% are actually allergic when properly tested.
- A penicillin allergy label is not a neutral piece of paperwork — it pushes you toward second-line antibiotics that are less effective for many infections, costlier, and more likely to drive antibiotic resistance.
- De-labeling is the formal process of confirming, in clinic, that you can safely take penicillin. For most patients it takes one or two visits.
- The CDC, the AAAAI, and major hospital systems now consider penicillin de-labeling a standard antibiotic-stewardship measure — not an optional extra.
- If your only "reaction" was a stomach upset, a childhood rash you can't describe, or a vague family story, you are an excellent de-labeling candidate.
The label that follows you for life
Most penicillin allergy labels come from one of three places: a parent who reported a childhood rash, a hospital intake form filled out in a hurry, or a single GI symptom that was probably a side effect rather than an allergy. The label gets entered into your chart and then it follows you through every hospitalization, every dental procedure, every UTI for the rest of your life.
The data on this is striking: the CDC's most cited public-health figure is that roughly 10% of the U.S. population carries a penicillin allergy label, but when those patients are properly evaluated, fewer than 1% have a true IgE-mediated penicillin allergy. The other 9% are either mislabeled, outgrew it, or had a reaction that wasn't actually allergic in nature.
That gap matters because the label is costly. Patients with a penicillin allergy label receive longer hospital stays (on average 0.6 days longer), more Clostridioides difficile (C. diff) infections, more MRSA, and more vancomycin-resistant infections — because the alternatives we use (vancomycin, clindamycin, fluoroquinolones) are broader-spectrum and disrupt the gut microbiome more. The label costs you. It also costs the rest of us, because broad-spectrum antibiotic use drives community antibiotic resistance.
Was your reaction actually allergic?
Most "reactions" that end up in the chart fall into one of these categories:
- A non-allergic side effect. Nausea, diarrhea, or yeast infections are not allergies. They are side effects. They do not justify a lifetime label.
- A rash from a viral illness that happened to be treated with amoxicillin. Classic example: a child gets a viral exanthem during a course of amoxicillin for a presumed bacterial infection; the rash is from the virus, not the drug. This is almost certainly the largest single bucket of mislabeling in the United States.
- A true IgE-mediated reaction (hives, swelling of the face/lips/tongue, wheezing, anaphylaxis within minutes to two hours). This is the real one we want to identify and respect.
- A severe delayed reaction (SJS, TEN, DRESS, AGEP). These are rare, dangerous, and a contraindication to any further beta-lactam exposure — de-labeling is not appropriate for these patients.
If you're not sure which category you're in, that's exactly what the de-labeling visit is for.
When a patient comes in carrying a penicillin allergy label, I usually start with one question: what actually happened? Half the time, the answer is something like "my mom said I had a reaction when I was three." That story alone is not a reason to spend the next forty years on second-line antibiotics.
— Dr. Joseph Damore, MD, Asthma Allergy Care & Treatment
How de-labeling works in clinic
A standard de-labeling pathway looks like this:
Step 1 — History and risk stratification. We spend 20 minutes walking through what happened, when, what the symptoms were, what you took, and what happened next. The vast majority of patients (the ones with mild or non-IgE reactions, or pure history-only labels) can move straight to a graded oral challenge.
Step 2 — Skin testing (when indicated). For patients whose history suggests possible IgE-mediated reaction (hives, swelling within minutes to hours), we do penicillin skin testing in the office: a small drop of major and minor penicillin determinants on the forearm. Read at 15–20 minutes.
Step 3 — Graded oral challenge. This is the gold-standard test. You take a small dose of amoxicillin in the office, wait an hour with us watching for any reaction, then take a full dose if all is well. Total time: 90 minutes to two hours. The vast majority of patients tolerate it without any reaction, and we update the chart that day.
Step 4 — Documentation. We send a letter to your primary care doctor, your dentist, and any specialist who needs to know. Most importantly, we update your electronic medical record so the next ER, urgent care, or hospital visit doesn't put you back into the same loop.
Who is a great candidate for de-labeling
- You have a penicillin allergy label but the story behind it is vague.
- Your only reaction was a stomach upset, headache, or yeast infection.
- Your only reaction was a childhood rash you don't remember.
- You haven't had penicillin in 10+ years (immune memory fades).
- You were told as a child but have never actually been tested.
- You're a candidate for a procedure or surgery that would benefit from first-line antibiotics (dental work, orthopedic surgery, obstetric care).
Who is not a candidate
- You had a confirmed severe delayed reaction (SJS, TEN, DRESS, AGEP).
- You had documented anaphylaxis to penicillin within the last few years.
- You have unstable cardiovascular or pulmonary disease that would make a challenge risky.
When to see an allergist
Book a de-labeling visit if:
- You carry a penicillin allergy label on your chart
- You don't have a clear memory of an allergic reaction
- You're planning a procedure or surgery in the next 6 months
- You've been getting recurrent infections that needed second-line antibiotics
Frequently asked questions
Can I be allergic to one penicillin (amoxicillin) but not another?
Possible but uncommon. True IgE-mediated penicillin allergy is usually class-wide because the immune response is to the core beta-lactam ring shared by all penicillins. Cross-reactivity with cephalosporins is much lower than the textbooks used to say — about 2%, and even less for newer cephalosporins.
What's the actual risk of an oral challenge?
For appropriately selected patients (no history of severe delayed reaction, no history of recent anaphylaxis), the risk of any reaction during a graded oral challenge is around 1–3%, and almost all of those reactions are mild (hives, rash). Serious reactions during a supervised in-office challenge are rare. We have epinephrine, IV access readiness, and monitoring throughout.
How long does the de-labeling result last?
Indefinitely. Once you're successfully challenged and tolerate amoxicillin, you've shown your immune system doesn't have IgE to penicillin. The label gets removed from your chart and stays removed.
Do I need to be off antihistamines before testing?
If we're doing penicillin skin testing, yes — we ask you to hold antihistamines for 5–7 days because they can mask a real positive. If we're going straight to an oral challenge based on your history, you can stay on your regular medications.
Is de-labeling covered by insurance?
It's billed as an in-office consultation plus a procedure. Most insurance plans cover it. If you'd like, we can verify your specific coverage before your visit.
Last reviewed
Last reviewed May 20, 2026 by Dr. Robert Tamayev, MD, PhD. Last substantive update May 20, 2026.
References
- Castells M et al. Penicillin Allergy. N Engl J Med. 2019;381:2338-2351.
- CDC. Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals — cdc.gov (accessed 2026-05-20).
- Shenoy ES et al. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019;321(2):188-199.
- AAAAI Practice Parameter. Drug Allergy: An Updated Practice Parameter — aaaai.org (accessed 2026-05-20).
- Macy E. Penicillin Allergy De-Labeling — Why Now? Ann Allergy Asthma Immunol. 2023;131(1):26-34.

